Make up a missed lesson-New policy to ensure the interchangeability of generic drugs in China-Reference-Cited by-同舟云学术

Make up a missed lesson-New policy to ensure the interchangeability of generic drugs in China

Published:2017-05-03 Issue:3 Volume:5 Page:e00318
ISSN:2052-1707
Container-title:Pharmacology Research & Perspectives
language:en
Short-container-title:Pharmacol Res Perspect

Author:

Huang Baobin¹^ORCID,Barber Sarah L.¹²,Xu Mingzhe¹,Cheng Shuanghong¹

Affiliation:

1. Division of General Management; National Institutes for Food and Drug Control and WHO Collaborating Centre for Drug Quality Assurance; No.2, Tiantanxili Dongcheng Beijing China

2. Health System Specialist; WHO Representative Office in South Africa; 351 Francis Baard (Schoeman) Street Pretoria South Africa

Publisher

Wiley

Subject

General Pharmacology, Toxicology and Pharmaceutics,Neurology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/prp2.318/fullpdf

Reference10 articles.

1. The need to cover generic medications and generic substitution practice in the curricula of pharmacy colleges in Saudi Arabia;Alrasheedy;Am J Pharm Educ,2014

2. The need to incorporate generic medicines topic in the curriculum of Yemeni pharmacy colleges;AL-Tamimi;Int J Pharm Pract,2016

3. Switching from originator brand medicines to generic equivalents in selected developing countries: how much could be saved?;Cameron;Value Health,2012

4. China Pharmaceuticals News 2016 Key aspects of re-evaluation of generic drugs in China (in Chinese) http://www.cnpharm.cn/yaopin/rdzz/20160322/98066.html

5. European Medicines Agency 2012 Questions and Answers on generic medicines http://www.ema.europa.eu/docs/en_GB/document_library/Medicine_QA/2009/11/WC500012382.pdf

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Influencing Factors of Generic Prescribing Behavior of Physicians: A Structural Equation Model Based on the Theory of Planned Behavior;Risk Management and Healthcare Policy;2024-05

2. Has the consistency evaluation policy of generic drugs promoted the innovation quality of Chinese pharmaceutical manufacturing industry? An empirical study based on the difference-in-differences model;Frontiers in Public Health;2023-12-01

3. Towards Sustainable Drug Supply in China: A Bibliometric Analysis of Drug Reform Policies;Sustainability;2023-06-25

4. An empirical study of the impact of generic drug competition on drug market prices in China;Frontiers in Public Health;2023-05-25

5. Pharmacokinetics and Bioequivalence of Fluconazole Capsules Manufactured in France and China in Healthy Chinese Participants: Open‐Label, Randomized, Single‐Dose, 2‐Way, Crossover Bioequivalence Study Under Fasted and Fed Conditions;Clinical Pharmacology in Drug Development;2023-04-10